News

This biotech’s stock rockets on oral obesity drug partnership with Wegovy parent
Novo Nordisk looks to harness Septerna’s broader GPCR drug pathways, which include GLP-1, for obesity and diabetes treatments ...
Bona Magazine39m
Mounjaro vs Ozempic: Which injection suits your diabetes needs?
Weekly jabs might not sound glamorous, but Mounjaro and Ozempic are making headlines for more than just managing blood sugar.